cannabichromene has been researched along with (6ar-trans)-isomer of tetrahydrocannabivarin 9 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunningham, CW | 1 |
| Ali, A; Banday, J; Bano, N; Bhat, AQ; Dar, MJ; Dar, MS; Nalli, Y; Rafia, B; Rasool, JU; Sarkar, AR; Vishwakarma, RA | 1 |
| Sampson, PB | 1 |
| Anderson, LL; Arnold, JC; Bowen, MT; Cairns, EA; Fletcher, C; Heblinski, M; Krycer, JR; Martin, LJ; McGregor, IS | 1 |
1 review(s) available for cannabichromene and (6ar-trans)-isomer of tetrahydrocannabivarin 9
| Article | Year |
|---|---|
Plant-Based Modulators of Endocannabinoid Signaling.
Topics: Cannabis; Endocannabinoids; Humans; Signal Transduction | 2019 |
3 other study(ies) available for cannabichromene and (6ar-trans)-isomer of tetrahydrocannabivarin 9
| Article | Year |
|---|---|
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
Topics: Animals; Cannabinoids; Cannabis; Cell Line, Tumor; Cell Proliferation; Humans; Neuralgia; Plant Leaves; Wnt Signaling Pathway | 2019 |
Phytocannabinoid Pharmacology: Medicinal Properties of
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Phytochemicals; Signal Transduction | 2021 |
Cannabichromene and Δ
Topics: Cannabinoids; Cannabis; Databases, Chemical; Dronabinol; Enzyme Inhibitors; Lactate Dehydrogenase 5; Molecular Docking Simulation; Molecular Structure | 2021 |